Master of Science in Experimental Medicine (MSc)
Experimental Medicine is the study of the pathogenesis and treatment of disease. Modern experimental medicine represents a rapidly growing body of knowledge involving the determination of diseases processes and the development of appropriate therapies.
The Experimental Medicine Program is intended for individuals seeking a career in research. The Department of Medicine offers opportunities and facilities for advanced studies in experimental medicine, leading toward the M.Sc. and Ph.D. degrees. Members of the Department direct research programs in a wide range of basic and clinically relevant areas. There are a variety of special interest areas of national and international stature. Specialties within the Experimental Medicine Program include: Cardiology, Endocrinology, Gastroenterology, Hematology, Infectious Diseases, Medical Immunology, Medical Oncology, Molecular Biology, Nephrology, Neurology and Respiratory Medicine.
Students may work with investigators located on the main campus of the University of B.C., or they may work in laboratories located off campus (Vancouver General Hospital, Jack Bell Research Centre, Terry Fox Laboratory, St. Paul's Hospital, Biomedical Research Centre, BC Children's Hospital).
It is not required to secure a supervisor at the time of the application, but the application will only be reviewed once a supervisor is secured.
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
Prior degree requirements
Applicants with a Bachelor in Science will be considered for entry to this program.
Deadline to submit online application. No changes can be made to the application after submission.Transcript Deadline
Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.Referee Deadline
Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.
September 2019 Intake
Application Open Date28 August 2018
Students who start in the M.Sc. program and who do not have a major scholarship, will receive a minimum stipend of $18,000 per year from their supervisor.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,665.26||$2,925.58|
|Tuition per year|
(plus annual increase, usually 2%-5%)
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$930.14 (approx.)|
|Costs of living (yearly)||starting at $16,884.10 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Completion Rates & Times
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
Afshar, Kourosh (Genital reconstruction and pediatric renal transplant)
Aparicio, Samuel (Breast cancer, genome sequencing )
Ashe, Maureen (Rehabilitation Care and Services, Social Aspects of Aging, Health Care Technologies, Osteoporosis, older adults, physical activity, tele-rehabilitation, systematic reviews, fracture, built environment)
Av-Gay, Yossef (Infectious Diseases, Microbiology, Drug discovery, Macrophage biology, Tuberculosis)
Avina Zubieta, Juan Antonio (Systemic Autoimmune Rheumatic Diseases (SARDs); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Long term effectiveness; Multivariate analyses; Outcomes assessment; Pharmaco-epidemiology)
Ayas, Najib (Public health and afety consequences of sleep apnea and sleep deprivation)
Beristain, Alexander Guillermo (Healthy Starts; cellular and molecular processes that direct trophoblast cell biology in early placental development; Examining the A Disintegrin And Metalloproteinase (ADAM) family in trophoblast biology; Examining the effects of obesity-associated inflammation on the maternal-fetal interface; Identifying gene expression differences in subpopulations of trophoblasts in normal and pathological pregnancies )
Blydt-Hansen, Tom (Childhood Diseases; Pediatric kidney transplant; Injury phenotype; Rejection; Biomarkers; Metabolomics; Chemokines)
Boyd, John (The cross-application of techniques from cardiovascular physiology and immunology has resulted in exciting discoveries, including proving for the first time that stimulation of Toll-Like Receptors expressed by cardiac myocytes resulted in cardiac contractile dysfunction)
Brauer, Michael (Environmental Health, Community Health / Public Health, air pollution, environmental health, built environment, environmental epidemiology, remote sensing)
Brunham, Liam (Genetic Diseases, Cardiovascular Diseases, Lipid Disorders, Stem Cells and Organogenesis)
Brussoni, Mariana (injury prevention, accident prevention, fathering, risk-taking )
Bryan, Stirling (Economics of health care, policy, from UK)
Buttyan, Ralph (Kidneys, Urinary System, Benign Bladder Dysfunctions)
Carleton, Bruce (Pharmacogenomics, Adverse drug reactions (ADRs), Drug safety and effectiveness, Clinical pharmacology, Pharmacovigilance)
Carlsten, Christopher (Environment and Respiratory Diseases)
Cashman, Neil (prion disease, bovine spongiform encephalopathy, Creutzfeldt-Jakob disease, amyotrophic lateral sclerosis, protein misfolding diseases, Alzheimer's)
Cherkasov, Artem (Drug design; Bioinformatics, Molecular modeling; Proteomics; Artificial intelligence; Antibiotics )
Chew, Ben (how kidney stones form and in particular intestinal absorption of minerals that can form kidney stones (calcium and oxalate); genetically modifying bacteria normally used to make yogurt to express a naturally occurring enzyme that breaks down oxalate, thus preventing its absorption into the body where it can combine with calcium to form kidney stones.)
Cibere, Jolanda (Arthritis / Osteo-Arthritis, early osteoarthritis, magnetic resonance imaging in osteoarthritis, biomarkers in osteoarthritis, progression of early osteoarthritis, clinical detection of early osteoarthritis)
Conway, Edward (Translational research, blood, hemostasis-thrombosis, transfusion, coagulation, hematology, transgenic mice, vascular biology, endothelial, immunity, bleeding, thrombosis, arthritis, Coagulation, innate immunity, endothelial medicine, inflammation, cardiovascular disease)
Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
Daley, Denise (Complex Trait Genetics, Genetic Diseases, Asthma, Susceptibility Genes, Genetics of Aging, genetic epidemiology, statistical genetics, epigenetics, gene-gene and gene-environment interactions)
Daugaard, Mads (Cell Signaling and Cancer, Cancer Diagnosis and Detection, Stress and Cancer, Immunotherapy, Cell Therapy of Cancer, Chemotherapy, Radiotherapy, Cancer biology, Glycobiology, DNA damage response pathways, Cancer therapy, Cancer diagnostics, Stress signalling in cancer, Immunotherapy)
De Vera, Mary (examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions.)